The only thing objective about one of my previous posts regarding BTGC getting back to 16 is that I bought it along with the rest of the herd baack about 2 years ago. I bought this stock prior to that strictly based on Fidelity S&P Newsletters recommending BTGC. Bought 3000 shrs at $7 Shr and within 3 - 6 months had a double. SOld and then bought back in at 16 1/4 which I thought was going to be a dip. Well, it's turned out to be a 2 1/2 year dip - thanks to this new drug test not doing great.
I keep watching my Fidelity newsletters, haven't continued coverage yet, but stay tuned.